Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
Automatic Liquid-based Cytology Processor
2023

Share:

Automatic Liquid-based Cytology Processor

Medical equipment

As the unmatched automatic AI diagnosis workstation for cervical cancer, it’s dedicated to making greater contributions to women’s health. With the algorithm model based on deep learning and AI analysis software, combined with pathological medical technology, this workstation realizes the analysis line integration of automatic filming, dyeing, digital scanning and AI-assisted diagnosis, which not only ensures the accuracy of screening results, but also further improves the doctor’s detection and diagnostic efficiency to cervical cancer.

Client / Manufacturer

SHENZHEN REETOO BIOTECHNOLOGY CO., LTD

Shenzhen, CN
Design

SHENZHEN REETOO BIOTECHNOLOGY CO., LTD

Shenzhen, CNXinqiang Luo, Qiaoliang Li, Suwen Qi
Date of Launch
2022
Development Time
up to 24 Month
Target Regions
Asia, Australia / Oceania
Target Groups
Trade / Industry

RELATED PROJECTS